Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 12 points (-0.1%) at 16,435 as of Friday, May 16, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,512 issues advancing vs. 1,401 declining with 184 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 1.9%, Grifols ( GRFS), down 1.9%, Community Health Systems ( CYH), down 1.7%, HCA Holdings ( HCA), down 1.2% and Humana ( HUM), down 1.1%. Top gainers within the industry include Intuitive Surgical ( ISRG), up 1.8%, CR Bard ( BCR), up 1.1%, Agilent Technologies ( A), up 1.0%, Boston Scientific ( BSX), up 0.8% and Waters ( WAT), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Centene ( CNC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Centene is down $1.30 (-1.9%) to $69.10 on light volume. Thus far, 187,824 shares of Centene exchanged hands as compared to its average daily volume of 598,100 shares. The stock has ranged in price between $69.04-$70.48 after having opened the day at $70.26 as compared to the previous trading day's close of $70.41.

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Managed Care and Specialty Services. Centene has a market cap of $4.0 billion and is part of the health care sector. Shares are up 19.4% year-to-date as of the close of trading on Thursday. Currently there are 8 analysts that rate Centene a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Centene as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Centene Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, DaVita HealthCare Partners ( DVA) is down $0.43 (-0.6%) to $67.30 on average volume. Thus far, 528,443 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $67.18-$68.10 after having opened the day at $67.60 as compared to the previous trading day's close of $67.73.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. DaVita HealthCare Partners has a market cap of $14.5 billion and is part of the health care sector. Shares are up 6.9% year-to-date as of the close of trading on Thursday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Aetna ( AET) is down $0.68 (-0.9%) to $74.05 on light volume. Thus far, 909,888 shares of Aetna exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $73.96-$75.00 after having opened the day at $74.78 as compared to the previous trading day's close of $74.73.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $26.9 billion and is part of the health care sector. Shares are up 8.9% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts that rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null